BSEOthers20 Aug 2026 · 20 Aug 2026, 03:26 pm

Dear Sir, Pursuant to Regulation 34(1) and Regulation 30 of SEBI(LODR),Regulations ,2015. Please find the attached our 40th Annual Report for the FY 2025-26. Kindly take the same on ....

Colinz Laboratories Ltd · 531210

✦ AI SummaryResults

Colinz Laboratories Ltd has announced its 40th Annual Report for FY 2025-26, along with the reappointment of directors and other business resolutions.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Colinz Laboratories Ltd - 531210 - Reg. 34 (1) Annual Report.

Attachments (1)

📄

3940b277-7f57-46e7-82c9-360944c6db5a.pdf

pdf

Download →
View document text
COLINZ LABORATORIES LIMITED (CIN: L24200MH1986PLC041128) 40th ANNUAL REPORT 2025-2026 33rd Annual Report 2018-2019 40th Annual Report COLINZ LABORATORIES LIMITED COMPANY’S CIN No. L24200MH1986PLC041128 NAME OF DIRECTOR DIN NO DESIGNATION DR. MANI L. S. 00825886 Director & Company Secretary(till 07-11-2025) Additional Director w.e.f. 11-11- MRS. VIJAYA MANI 11363910 2025 BOARD OF DIRECTORS SHRI. N. K. MENON 01111297 Whole-Time Director SHRI. BHAVIK ASHOKKUMAR SHAH 09605363 Independent Director SHRI. BAPTIST BENARD DIAS 00854083 Independent Director Company Secretary & Company Secretary & Compliance Officer MRS. FALGUNI KUMAWAT ------ Compliance Officer CFO SHRI. GANESH S. CHITTE ---- Chief Financial Officer VORA & ASSOCIATES STATUTORY AUDITORS Chartered Accountants (Firm Regn. No. 111612W ) SECRETARIAL AUDITOR CS SANJAY R. DHOLAKIA (M. No. 2655/CP No. 1798) BANKER’S BANK OF BARODA. REGISTERED OFFICE A-101, PRATIK IND. ESTATE, MULUND-GOREGAON LINK ROAD BHANDUP(W), MUMBAI – 400 078 EMAIL ID colinzlabs@yahoo.com WEBSITE www.findoc-cll.in CONTENTS Page No. NOTICE 2 DIRECTORS REPORT 16 REPORT ON CORPORATE GOVERNANCE 23 MANAGEMENT DISCUSSION & ANALYSIS 36 SECRETARIAL AUDIT REPORT 37 INDEPENDENT AUDITORS’ REPORT 42 NOTES FORMING PART OF THE FINANCIAL STATEMENT 52 BALANCE SHEET 59 PROFIT AND LOSS ACCOUNT 60 STATEMENT OF CHANGES IN EQUITY 68 CASH FLOW STATEMENT 69 Request: all are requested to convert their shares from physical mode to demat as per SEBI(LODR)/Company’s Act. NOTICE NOTICE is hereby given that the Fortieth (40th) Annual General Meeting (AGM) of the members of M/s. COLINZ LABORATORIES LIMITED (CIN: L24200MH1986PLC041128) (“the Company”) will be held on Tuesday, 22nd September, 2026, at 2.30 P. M.(IST) through Video Conferencing or Other Audio Video Means (OAVM) for which purposes the Registered Office of the Company situated at A-101, Pratik Industrial Estate, Mulund-Goregaon Link Road, Bhandup(W), Mumbai - 400 078, shall be deemed as the venue for the Meeting and the proceedings of the Annual General meeting shall be deemed to be made there at, to transact the following business: ORDINARY BUSINESS :- Item No. 1- Adoption of Audited Financial Statements and Reports of the Directors and Independent Auditors thereon. To receive, consider and adopt the Audited Financial Statements containing Balance Sheet as at 31st March, 2026, the Statement of Profit and Loss, Cash Flow for the financial year ended 31st March, 2026 (Financial Documents) and Report of the Board of Directors and the Independent Auditors’ thereon and in this regard, pass the following resolution as an ordinary resolution; “RESOLVED THAT the audited financial statements of the Company for the financial year ended 31st March, 2026 (Financial Documents) and the reports of the Board of Directors and Independent Auditors’ thereon, as circulated to the members and laid before this meeting, be and are hereby considered and adopted.” Item No. 2 – Re-appointment of a Director Mr. N. K. Menon (DIN- 01111297) who retires by rotation and being eligible offers himself for reappointment. To appoint a Director in place of Mr. N. K. Menon (DIN- 01111297) who retires by rotation and being eligible offers himself for re-appointment and in this regard pass the following resolution as an ordinary resolution; “RESOLVED THAT pursuant to the provision of section 152(6) of the Companies Act, 2013 Mr. N. K. Menon (DIN- 01111297), who retires by rotation at this meeting, be and is hereby appointed as a Director of the Company, liable to retire by rotation.” SPECIAL BUSINESS(S): Item No. 3 – Appointment of Mrs. Vijaya Mani (DIN: 11363910) as Director (Non-Executive, Non- Independent Director) of the Company. To consider and if thought fit, to pass, with or without modification the following resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to the provisions of Section 152 and other applicable provisions, if any, of the Companies Act, 2013 (‘the Act’) and the Companies (Appointment and Qualification of Directors) Rules, 2014 (including any statutory modification(s) or re-enactment(s) thereof for the time being in force), and applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘ SEBI Listing Regulations’) including any amendments thereof, Mrs. Vijaya Mani (DIN: 11363910), who was appointed by the Board of Directors as an Additional Director of the Company with effect from 11th November, 2025 under Section 161 of the Act and the Articles of Association of the Company and who is eligible for appointment as a Director of the Company and in respect of whom the Company has received a Notice in writing from a Member under Section 160 of the Act, proposing her candidature for the office of Director, be and is hereby appointed as a Director (Category: Promoter, Non-Executive) of the Company, liable to retire by rotation; RESOLVED FURTHER THAT approval of the Members be accorded to the Board of Directors to do all such acts, deeds, matters and things and to take all such steps as may be required in this connection to give effect to this resolution and to settle any questions, difficulties or doubts that may arise in this regard and further to execute all necessary documents, applications, returns and writings as may be necessary, proper, desirable or expedient.” Item No. 4 – Reappointment of Mr. N. K. Menon as as Whole Time Director & Chief Executive Officer and payment of remuneration. To consider and if thought fit, to pass, with or without modification the following resolution as a Special Resolution: “RESOLVED THAT pursuant to the provisions of Sections 196, 197, 203 and any other applicable provisions, if any, read along with Schedule V of the Companies Act, 2013 (‘Act’) and the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, as amended from time to time, the consent of the Members be and is hereby accorded to the re-appointment and terms of remuneration of Mr. N. K. Menon (Din No – 01111297) as Whole-Time Director & Chief Executive Officer (‘WTD & CEO’) of the Company for a period of 1 ( One ) year with effect from 1st October, 2026 to 30th September, 2027 (liable for retirement by rotation as a Director) on terms and conditions set out in the statement annexed to the notice convening this meeting including the remuneration to be paid in the event of loss or inadequacy of profits in any financial year during his said tenure within the overall limits of Section 197 of the Act, as recommended by the Nomination and Remuneration Committee, with liberty to the Board of Directors to alter and vary the terms and conditions of the said re-appointment and terms of remuneration as it may deem fit and in such manner as may be agreed to between the Board and WTD & CEO subject to the same not exceeding the limits specified under schedule V of the Companies Act 2013 and or any statutory modification ( s) or re-enactment thereof. RESOLVED FURTHER THAT the Board of Directors (the ‘Board’ which term includes a duly constituted Committee of the Board) to do all acts and take all such steps as may be necessary, proper or expedient to give effect to this resolution.” By order of the Board of Directors COLINZ LABORATORIES LIMITED (CIN: L24200MH1986PLC041128) Vijaya Mani Director DIN-11363910 Registered Office: Date : 30th July, 2026 A-101, Pratik Industrial Estate, Place : Mumbai Mulund-Goregaon Link Road, Bhandup (W), Mumbai-400078 Email ID : Colinzlabs@yahoo.com Website : www.findoc-cll.in EXPLANATORY STATEMENT PURSUANT TO SECTION 102 (1) OF THE COMPANIES ACT, 2013 The following Statement set out all material facts relating to Item Nos. 3 & 4 mentioned in the accompanying Notice. ITEM NO 3 : Appointment of Mrs. Vijaya Mani (DIN: 11363910) as Director (Non-Executive, Non- Independent Director) of the Company Mrs. Vijaya Mani (DIN: 11363910) was appointed as an Additional Director (Category: Promoter, Non [Showing first 8,000 characters — download PDF for full document]